PT78380B - Ph independent controlled release tablets - Google Patents

Ph independent controlled release tablets Download PDF

Info

Publication number
PT78380B
PT78380B PT78380A PT7838084A PT78380B PT 78380 B PT78380 B PT 78380B PT 78380 A PT78380 A PT 78380A PT 7838084 A PT7838084 A PT 7838084A PT 78380 B PT78380 B PT 78380B
Authority
PT
Portugal
Prior art keywords
dipyridamole
tablet
acid
incorporated
weight
Prior art date
Application number
PT78380A
Other languages
English (en)
Portuguese (pt)
Other versions
PT78380A (en
Original Assignee
Boehringer Ingelheim Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Ltd filed Critical Boehringer Ingelheim Ltd
Publication of PT78380A publication Critical patent/PT78380A/pt
Publication of PT78380B publication Critical patent/PT78380B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Materials For Medical Uses (AREA)
PT78380A 1983-04-08 1984-04-06 Ph independent controlled release tablets PT78380B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US48328583A 1983-04-08 1983-04-08

Publications (2)

Publication Number Publication Date
PT78380A PT78380A (en) 1984-05-01
PT78380B true PT78380B (en) 1986-08-14

Family

ID=23919470

Family Applications (1)

Application Number Title Priority Date Filing Date
PT78380A PT78380B (en) 1983-04-08 1984-04-06 Ph independent controlled release tablets

Country Status (20)

Country Link
EP (1) EP0121901B1 (enExample)
JP (1) JPS6034906A (enExample)
KR (1) KR880002139B1 (enExample)
AT (1) ATE32980T1 (enExample)
AU (1) AU570446B2 (enExample)
CA (1) CA1219216A (enExample)
DD (1) DD222496A5 (enExample)
DE (1) DE3469848D1 (enExample)
DK (1) DK166259C (enExample)
ES (1) ES8601687A1 (enExample)
FI (1) FI82604C (enExample)
GR (1) GR81907B (enExample)
HU (1) HU191542B (enExample)
IE (1) IE57220B1 (enExample)
IL (1) IL71458A (enExample)
NO (1) NO164958C (enExample)
NZ (1) NZ207768A (enExample)
PH (1) PH21585A (enExample)
PT (1) PT78380B (enExample)
ZA (1) ZA842562B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5188840A (en) * 1985-09-26 1993-02-23 Chugai Seiyaku Kabushiki Kaisha Slow-release pharmaceutical agent
JPH0776172B2 (ja) * 1986-04-16 1995-08-16 藤沢薬品工業株式会社 マトリツクス錠
JP2535141B2 (ja) * 1995-01-17 1996-09-18 中外製薬株式会社 フマル酸含有徐放性製剤
DE10337697A1 (de) * 2003-08-16 2005-03-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tablette enthaltend 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenyl-amino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester oder dessen Salze
BG860Y1 (bg) * 2004-09-17 2007-02-28 "Софарма" Ад Лекарствена форма на дипиридамол
EP1919460A2 (en) * 2005-08-22 2008-05-14 Novartis AG Pharmaceutical compositions comprising a ph-dependent drug, a ph modifier and a retarding agent
CA2671470C (en) 2006-12-13 2012-05-01 F. Hoffmann-La Roche Ag Powder formulation for valganciclovir

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
DD146547A5 (de) * 1978-07-15 1981-02-18 Boehringer Sohn Ingelheim Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen
DE3000979A1 (de) * 1980-01-12 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach Neue dipyridamol-retardformen und verfahren zu ihrer herstellung
DE3124090A1 (de) * 1981-06-19 1983-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale dipyridamolformen
JPS5839618A (ja) * 1981-09-04 1983-03-08 Chugai Pharmaceut Co Ltd 持続性積層錠剤

Also Published As

Publication number Publication date
DK166259B (da) 1993-03-29
PT78380A (en) 1984-05-01
DK181084A (da) 1984-10-09
ES531346A0 (es) 1985-11-01
IE57220B1 (en) 1992-06-03
GR81907B (enExample) 1984-12-12
EP0121901B1 (en) 1988-03-16
AU2660984A (en) 1984-10-11
NO841372L (no) 1984-10-09
HUT34345A (en) 1985-03-28
JPS6034906A (ja) 1985-02-22
KR840008588A (ko) 1984-12-17
PH21585A (en) 1987-12-11
IE840856L (en) 1984-10-08
DK181084D0 (da) 1984-04-06
FI82604B (fi) 1990-12-31
DK166259C (da) 1993-08-23
NO164958B (no) 1990-08-27
EP0121901A1 (en) 1984-10-17
CA1219216A (en) 1987-03-17
IL71458A0 (en) 1984-07-31
ATE32980T1 (de) 1988-04-15
AU570446B2 (en) 1988-03-17
JPH0521892B2 (enExample) 1993-03-25
ES8601687A1 (es) 1985-11-01
DE3469848D1 (en) 1988-04-21
FI82604C (fi) 1991-04-10
NO164958C (no) 1990-12-05
KR880002139B1 (ko) 1988-10-17
NZ207768A (en) 1987-02-20
ZA842562B (en) 1985-12-24
IL71458A (en) 1987-09-16
HU191542B (en) 1987-03-30
DD222496A5 (de) 1985-05-22
FI841369L (fi) 1984-10-09
FI841369A0 (fi) 1984-04-06

Similar Documents

Publication Publication Date Title
KR890004688B1 (ko) 서방형 약제의 담체 조성물
JP2895146B2 (ja) 二重作用錠剤
ES2234302T3 (es) Formulaciones de ranolacina de liberacion sostenida.
ES2287333T3 (es) Comprimidos de tamsulosina de liberacion modificada.
KR100463496B1 (ko) 고가용성 약물용 서방성 메트리스 시스템
HUP0101517A2 (hu) Efavirenz hatóanyagot tartalmazó, gyorsan oldódó kapszulák és tabletták, valamint eljárás ezek előállítására
US6048547A (en) Process for manufacturing solid compositions containing polyethylene oxide and an active ingredient
CZ298371B6 (cs) Dávkovací forma ibuprofenu a zpusob její prípravy
KR0151131B1 (ko) 분산성 고체 약제
JPH0733330B2 (ja) 弾性被膜を有する安定な固形調剤及びその製造方法
US20070104785A1 (en) Tablets of linezolid form iii and processes for their preparation
ES2224256T3 (es) Disolucion solida de un agente antifungico con biodisponibilidad mejorada.
JP2609022B2 (ja) ポリカルボフィルカルシウム含有製剤
HU228179B1 (en) Pharmaceutical, oral compositions containing 5-ht4 agonists or antagonists as active agent
JPS6051106A (ja) 塩酸アモスラロ−ル持続性製剤
PT78380B (en) Ph independent controlled release tablets
Khattab et al. Effect of Mode of Incorporation of Disintegrants on the Characteristics of Fluid‐bed Wet‐granulated Tablets
KR100296413B1 (ko) 세파클러함유서방성정제
KR20220097340A (ko) 장세척을 위한 경구용 고형제제
US20090155369A1 (en) Pharmaceutical composition containing levodopa, entacapone and carbidopa
JP3836893B2 (ja) ポリカルボフィルカルシウム含有製剤
EP3429562A1 (en) Compositions of deferasirox
WO2000078291A1 (en) Composition of paroxetine methanesulfonate
US20090298944A1 (en) Pharmaceutical composition
JPH0737383B2 (ja) 胃酸分泌抑制剤含有固型製剤